IP Library Granted Patent US 8,852,077
Granted Patent B2
US 8,852,077 · App. 13/903,474 · Granted Oct 7, 2014

Sling delivery system and method of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,852,077
App. No.
13/903,474
Granted
Oct 7, 2014
Kind
B2
Abstract

An apparatus and method of use are disclosed to treat urological disorders. The biocompatible device includes a handle, needle, dilator and sling assembly configured to be minimally invasive and provide sufficient support to the target site. In addition, the configuration of the sling assembly also allows the sling to be adjusted during and/or after implantation. The device and treatment procedure are highly effective and produce little to no side effects or complications. Further, operative risks, pain, infections and post operative stays are reduced, thereby improving patient quality of life.

Claims (56)

1. A surgical assembly useful for treating urinary incontinence in a patient, the assembly comprising:

a needle sized and shaped to extend substantially between an abdominal wall and vaginal tissue of a female patient, comprising a distal end and a proximal end;

a length of implantable mesh comprising

a middle portion,

a first elongate end section extending from the middle portion to a first distal end and capable of extending between the abdominal wall and the vaginal tissue, and

a second elongate end section extending from the middle portion to a second distal end and capable of extending between the abdominal wall and the vaginal tissue,

a first sheath about at least a portion of the first elongate end section,

a second sheath about at least a portion of the second elongate end section, and

a connector comprising a connector proximal end and a connector distal end, the connector proximal end attached to the first elongate end section, the first sheath, or both, and the connector distal end adapted to engage the distal end of the needle in a manner that allows the needle to pull the connector through tissue.

2. The assembly of claim 1 wherein the needle comprises a handle attached to the proximal end.

3. The assembly of claim 2 comprising the needle and a second needle, the second needle sized and shaped to extend substantially between an abdominal wall and vaginal tissue of a female patient.

4. The assembly of claim 2 comprising

the needle and a second needle, the second needle sized and shaped to extend substantially between an abdominal wall and vaginal tissue of a female patient, the assembly comprising a second handle attached to a proximal end of the second needle, and

a tension adjusting member extending along a length of the first elongate end section, a length of the middle portion, and a length of the second elongate end section,

wherein

the first sheath covers the first elongate end section, the second sheath covers the second elongate end section, an end of the first sheath is located at the middle portion and an end of the second sheath is located at the middle portion.

5. The assembly of claim 4 wherein the end of the first sheath overlaps the end of the second sheath.

6. The assembly of claim 1 comprising a tension adjustment member extending along a length of at least one of the first elongate end section and the second elongate end section.

7. The assembly of claim 6 wherein the tension adjusting member comprises a suture extending along a length of the first elongate end section, a length of the middle portion, and a length of the second elongate end section.

8. The assembly of claim 1 wherein the first sheath covers the first elongate end section, the second sheath covers the second elongate end section, an end of the first sheath is located at the middle portion and an end of the second sheath is located at the middle portion.

9. The assembly of claim 8 wherein the end of the first sheath overlaps the end of the second sheath.

10. The assembly of claim 1 comprising the needle and a second needle, the second needle sized and shaped to extend substantially between an abdominal wall and vaginal tissue of a female patient.

11. The assembly of claim 10 comprising the connector and a second connector attached to the second elongate end section, the second sheath, or both, the second connector comprising a second connector proximal end and a second connector distal end, the second connector proximal end attached to the second elongate end section, the second sheath, or both, and the second connector distal end adapted to engage the distal end of the second needle in a manner that allows the second needle to pull the second connector through tissue.

12. The assembly of claim 11 wherein the first connector is a first dilating connector and the second connector is a second dilating connector.

13. The assembly of claim 12 wherein the first dilating connector includes a tapered surface and the second dilating connector includes a tapered surface.

14. The assembly of claim 12 wherein the first dilating connector includes a tapered surface and the second dilating connector includes a tapered surface.

15. A surgical device according to claim 11 wherein the first connector is shaped to deflect tissue out of the path of the first connector and the second connector is shaped to deflect tissue out of the path of the second connector.

16. A method of treating urinary incontinence in a female patient comprising the steps of:

creating at least one incision in vaginal tissue,

creating one or more suprapubic incision,

providing an assembly according to claim 1 ,

passing the needle between the at least one vaginal incision and the one or more suprapubic incision,

using the needle to pass the first elongate end section through tissue of the patient between the at least one vaginal incision and the one or more suprabubic incision to locate the implantable mesh in a therapeutically effective position relative to the urethra of the patient, and

removing the first sheath.

17. The method of claim 16 comprising passing the second elongate end section through tissue of the patient between the at least one vaginal incision and the one or more suprabubic incision and removing the second sheath.

18. The method of claim 16 wherein

passing the needle between the at least one vaginal incision and the one or more suprapubic incision comprises inserting a first end of the needle into the one or more suprapubic incision and passing the first end of the needle through tissue of the patient to the at least one vaginal incision; and

passing the second needle between the at least one vaginal incision and the one or more suprapubic incision comprises inserting a first end of the second needle into the one or more suprapubic incision and passing the first end of the second needle through tissue of the patient to the at least one vaginal incision.

19. The method of claim 18 wherein the assembly comprises:

the connector and a second connector attached to the second elongate end section, the second sheath, or both, and adapted to engage the second needle; and

the needle and a second needle, the second needle sized and shaped to extend substantially between an abdominal wall and vaginal tissue of a female patient.

20. The method of claim 19 comprising

with the needle located between the at least one vaginal incision and the one or more suprapubic incision, connecting the connector to the first end of the needle,

with the second needle located between the at least one vaginal incision and the one or more suprapubic incision, connecting the second connector to the first end of the second needle,

removing the needle from the patient by pulling the needle from the one or more suprapubic incision to pass the first elongate end section through tissue of the patient between the at least one vaginal incision and the one or more suprabubic incision; and

removing the second needle from the patient by pulling the second needle from the one or more suprapubic incision to pass the second elongate end section through tissue of the patient between the at least one vaginal incision and the one or more suprabubic incision.

21. A method of treating urinary incontinence in a female patient comprising the steps of:

creating at least one incision in vaginal tissue,

creating one or more suprapubic incision,

providing an assembly according to claim 1 comprising the needle sized and shaped to extend substantially between an abdominal wall and vaginal tissue of a female patient, and a second needle sized and shaped to extend substantially between an abdominal wall and vaginal tissue of a female patient;

passing the needle between the at least one vaginal incision and the one or more suprapubic incision;

passing the second needle between the at least one vaginal incision and the one or more suprapubic incision;

using the needle to pass the first elongate end section through tissue of the patient between the at least one vaginal incision and the one or more suprabubic incision;

removing the first sheath;

using the second needle to pass the second elongate end section through tissue of the patient between the at least one vaginal incision and the one or more suprabubic incision to locate the implantable mesh in a therapeutically effective position relative to the urethra of the patient; and

removing the second sheath.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: ASTORA WOMEN'S HEALTH, LLC
To: STASKIN, DAVID, MD, DR
Reel/Frame 045605/0796 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →